Cardiff Oncology Inc (NAS:CRDF)
$ 3.44 0.14 (4.24%) Market Cap: 153.85 Mil Enterprise Value: 88.66 Mil PE Ratio: 0 PB Ratio: 2.53 GF Score: 53/100

Cardiff Oncology Inc at Piper Sandler Healthcare Conference Transcript

Nov 29, 2022 / 06:30PM GMT
Release Date Price: $1.46 (+3.55%)
Joe Catanzaro
Piper Sandler - Analyst

Yeah. Okay, great. Well, thanks, everybody, for joining us here at Piper Sandler's Annual Healthcare Conference. I'm Joe Catanzaro from the Piper biotech team. It's my pleasure to welcome Cardiff Oncology CEO, Mark Erlander. Mark, thanks so much for joining us here.

A lot to get through in these next 25 minutes or so, but maybe first, you could just sort of level set, give us a little update on Cardiff, what you guys have been up to and then we can jump into some specific questions.

Mark Erlander
Cardiff Oncology, Inc. - CEO

Well, I mean, it's exciting times at Cardiff. And by the way, thank you for giving us the opportunity to talk about Cardiff here at the Piper conference.

Some of the really big things that are happening at Cardiff Oncology is that we're really gearing up for our ONSEMBLE, which is a randomized trial in KRAS mutant metastatic CRC. I think that's one of the really big things that's happening.

We also just -- September 12 of last -- of this year, we reported out really

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot